Bio-Techne Corporation (FRA:TE1)

Market Cap	8.55B
Revenue (ttm)	1.04B
Net Income (ttm)	66.44M
Shares Out	n/a
EPS (ttm)	0.41
PE Ratio	128.63
Forward PE	31.46
Dividend	0.29 (0.51%)
Ex-Dividend Date	Nov 17, 2025

Volume	n/a
Average Volume	n/a
Open	55.00
Previous Close	55.50
Day's Range	54.50 - 55.00
52-Week Range	40.60 - 75.50
Beta	n/a
RSI	56.83
Earnings Date	Jan 30, 2026

About Bio-Techne

Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research, diagnostics, and bioprocessing markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Spatial Biology. The Protein Sciences segment develops and manufactures biological reagents used in various aspects of life science research, diagnostics, and cell and gene therapy, such as cytokines and growth factors, antibodies, small molecules, tissue cultur...

• Industry: Biological Products, Except Diagnostic Substances
• Founded: 1976
• Employees: 3,100
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: TE1

Financial Performance

In 2025, Bio-Techne's revenue was $1.22 billion, an increase of 5.23% compared to the previous year's $1.16 billion. Earnings were $73.36 million, a decrease of -56.35%.

Financial numbers in USD